This article briefly presents the main characteristics of the World Health Organization (WHO) essential medicines list (EML), a register of minimum medicine needs for every health-care system. The idea behind the list is that the use of a limited number of well-known and cost-effective medicines may lead to improved long-term medicine supply, lower costs and better health care provision
Medicines are as important as health care workers. In developing countries patients has to travel ma...
The selection of cancer medicines for national procurement requires deliberate evaluation of populat...
To investigate the use of the WHO EML as a tool with which to evaluate the evidence base for the med...
Objectives: Essential medicines lists (EMLs) are efficient means to ensure access to safe and effect...
Pressures to include more cancer medicines in the WHO Model List of Essential Medicines (EML) pose c...
BackgroundNon-communicable diseases (NCDs) are the leading cause of death worldwide. Inadequate and ...
The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (...
Since 1977 the World Health Organization publishes a list of Essential Medicines, i.e. those that sa...
The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in int...
The selection of cancer medicines for national procurement requires deliberate evaluation of populat...
Since the establishment of the concept of “essential medicines ” by the World Health Organization (W...
Objectives Examining the availability of essential medicines is a necessary step to monitor country-...
BACKGROUND: The World Health Organization (WHO) promotes the development of national Essential Medic...
BackgroundIn 1977 the World Health Organization created its first Model List of Essential Medicines—...
Currently, 160 countries have formal essential medicines lists. More than 90 % of the low- and mid-i...
Medicines are as important as health care workers. In developing countries patients has to travel ma...
The selection of cancer medicines for national procurement requires deliberate evaluation of populat...
To investigate the use of the WHO EML as a tool with which to evaluate the evidence base for the med...
Objectives: Essential medicines lists (EMLs) are efficient means to ensure access to safe and effect...
Pressures to include more cancer medicines in the WHO Model List of Essential Medicines (EML) pose c...
BackgroundNon-communicable diseases (NCDs) are the leading cause of death worldwide. Inadequate and ...
The World Health Organization (WHO) promotes the development of national Essential Medicines Lists (...
Since 1977 the World Health Organization publishes a list of Essential Medicines, i.e. those that sa...
The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in int...
The selection of cancer medicines for national procurement requires deliberate evaluation of populat...
Since the establishment of the concept of “essential medicines ” by the World Health Organization (W...
Objectives Examining the availability of essential medicines is a necessary step to monitor country-...
BACKGROUND: The World Health Organization (WHO) promotes the development of national Essential Medic...
BackgroundIn 1977 the World Health Organization created its first Model List of Essential Medicines—...
Currently, 160 countries have formal essential medicines lists. More than 90 % of the low- and mid-i...
Medicines are as important as health care workers. In developing countries patients has to travel ma...
The selection of cancer medicines for national procurement requires deliberate evaluation of populat...
To investigate the use of the WHO EML as a tool with which to evaluate the evidence base for the med...